Table 3.
Control group, % (n/N) | Telemonitoring group, % (n/N) | RR (95% CI) | P value | |
---|---|---|---|---|
Original analysis of the primary outcomea | 23.7 (137/578) | 18.2 (87/477) | 0.77 (0.62–0.98) | .03 |
Post hoc sensitivity analyses | ||||
1. Excluding patients in the telemonitoring group who did not access the telemonitoring device at least onceb | 23.7 (137/578) | 12.2 (51/419) | 0.51 (0.38–0.69) | < .001 |
2. Assuming the rate of the primary outcome is the same as the cohort of study participants—21.2%c | 23.3 (161/690) | 19.1 (132/690) | 0.82 (0.6–1.01) | .056 |
3. Assuming the rate of the primary outcome is the same as the control group—23.7%c | 23.8 (164/690) | 19.8 (137/690) | 0.83 (0.68–1.02) | .08 |
Abbreviation: RR, relative risk
aThe primary outcome was a composite of 30-day death or hospital readmission
bExcluded 58 patients in telemonitoring group who did not access the telemonitoring device at least once; 36 of the 58 excluded patients had 30-day death or hospital readmission
cTwo post hoc sensitivity analyses were used to evaluate the impact of missing outcomes on our results. In the first scenario, the missing composite outcomes were assigned the rate of the cohort of study participants. In the second scenario, the missing composite outcomes were assigned the rate of the control arm